RemedyRepack Inc. has recalled Metformin 750 mg Extended Release, a prescription medication used for diabetes, because testing detected levels of N-Nitrosodimethylamine (NDMA) that exceed acceptable daily intake limits. The recall involves 56 blister cards that were distributed to a single direct account in Pennsylvania. Consumers using this medication should not stop taking it without first consulting their healthcare provider, as the risk of untreated diabetes may outweigh the risk of the impurity.
NDMA is classified as a probable human carcinogen, and long-term exposure to levels above the safety limit may increase the risk of cancer. No injuries or illnesses have been reported in connection with this recall.
You have 2 options:
Recall #: D-0366-2022; Quantity: 56 Blister Cards
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.